Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2022

Genmab — Februar 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #20

    if you go to their site ugebrev it should be there for members (not me 😉 )

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #21

      God morgen. 🙂

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #22

        Asien: Markant positiv positiv påvirkning fra Wall Street - NY
        https://www.proinvestor.com/investornyt/774792/asien-markant-positiv-positiv-pavirkning-fra-wall-street-ny

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #23

          Onsdagens aviser med Novozymes, Danske Bank og FLSmidth - NY
          https://www.proinvestor.com/investornyt/774796/onsdagens-aviser-med-novozymes-danske-bank-og-flsmidth-ny

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #24

            Obligationer/tendens: Fortsat høj rente i sigte med fokus på inflation
            https://www.proinvestor.com/investornyt/774799/obligationer-tendens-fortsat-hoj-rente-i-sigte-med-fokus-pa-inflation

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #25

              Kesimpta Full year USD 372 million (Q4 USD 147 million) sales were driven by launch uptake, strong access and increased
              demand based on a superior benefit-risk profile; now approved in 64 countries

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #26

                novartis press release

                https://www.novartis.com/news/media-releases/novartis-delivers-mid-single-digit-sales-growth-margin-expansion-and-advancement-robust-pipeline-2021 and presentation https://www.novartis.com/sites/novartis_com/files/q4-2021-investor-presentation.pdf

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #27

                  Pretty strong acceleration

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #28

                    yes, and 64 countries already is impressive. and I assume there will be no sales 'free of charge'
                    anymore in 2022

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      deleted-user
                      wrote on sidst redigeret af
                      #29

                      I stand by that assumption. We are gonna get close to a third BB i 2022 ?

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        deleted-user
                        wrote on sidst redigeret af
                        #30

                        or no 3 and 4 🙂

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #31

                          pfff... not impossible, but steep... you would need >35% Q/Q growth... then again, covid clearly was a hurdle for Kesimpta in '21, if that would fall away...

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #32

                            Aktier/tendens: Novo kan klare sig bedre end ellers grønt marked
                            https://www.proinvestor.com/investornyt/774816/aktier-tendens-novo-kan-klare-sig-bedre-end-ellers-gront-marked

                            1 Reply Last reply
                            0
                            • D Offline
                              D Offline
                              deleted-user
                              wrote on sidst redigeret af
                              #33

                              Åbner vi over 2300? Ja det må tiden jo vise, men det blive nok grønt

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #34

                                Novo Nordisk confirm: in November 2021 successfully completed the first cohorts from the ongoing phase 1/2 clinical trial with Mim8

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #35

                                  Aktier/åbning: Novo og Ørsted i udbrud i grønt C25
                                  https://www.proinvestor.com/investornyt/774828/aktier-abning-novo-og-orsted-i-udbrud-i-gront-c25

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #36

                                    https://www.proinvestor.com/boards/97931#postdiv100653 nye købs signaler - kurs 2647

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #37

                                      sorry @StockBull , but we can not accept any targets below 3000 😉

                                      1 Reply Last reply
                                      0
                                      • StockBullS Offline
                                        StockBullS Offline
                                        StockBull
                                        wrote on sidst redigeret af
                                        #38

                                        oohh this is just a 20-30 days target - still around 3500 4-6 month month from now 🙂

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #39

                                          lol that's the spirit

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper